North American anticoagulants market is estimated to grow at a CAGR of 7.2% during the forecast period. Some pivotal factors encouraging the market growth include the rising prevalence of heart diseases and increasing FDA approvals for anticoagulants drugs. As per the Centers for Disease Control and Prevention (CDC), in the US, someone has a heart attack every 40 seconds. This is leading to an increasing demand for anticoagulants that are known as blood thinners. It supports prevention of blood clots and are recommended for people who at a high risk of getting clots. It aims to decrease their possibility of developing severe conditions including heart attacks and strokes.
Get Free Sample link @ https://www.omrglobal.com/request-sample/north-american-anticoagulants-market
The market is segmented based on type and application. Based on type, the market is classified into novel oral anticoagulants (NOACs), vitamin k antagonist, and heparin, and low molecular weight heparin (LMWH). A vitamin K antagonist is utilized for the treatment of thromboembolism with cardiac valve replacement, thromboembolic events post myocardial infarction, venous thromboembolism, pulmonary embolism, and thromboembolism with atrial fibrillation. In vitamin K antagonist (VKA) anticoagulant, warfarin is the most commonly utilized medication in the US to reduce the risk of stroke in certain atrial fibrillation patients with risk factors. Based on application, the market is classified into pulmonary embolism, atrial fibrillation/myocardial infarction (heart attack), deep vein thrombosis, and others.
A full report of North American Anticoagulants Market available @ https://www.omrglobal.com/industry-reports/north-american-anticoagulants-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
North American Anticoagulants Market by Type
- Novel Oral Anticoagulants (NOACs)
- Vitamin K Antagonist
- Heparin and Low Molecular Weight Heparin (LMWH)
North American Anticoagulants Market by Application
- Pulmonary Embolism
- Atrial Fibrillation/Myocardial Infarction (Heart Attack)
- Deep Vein Thrombosis (DVT)
- Others
Regional Analysis
- United States
- Canada
Company Profiles
- Abbott Laboratories
- Baxter International Inc.
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Company, Ltd.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer Inc.
- Portola Pharmaceuticals, Inc.
The Report Covers
- Comprehensive research methodology of the North American anticoagulants market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American anticoagulants market.
- Insights about market determinants that are stimulating the North American anticoagulants market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-anticoagulants-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
